Taken together there is good evidence thatacetylation of p53 promotes sense-cence and apoptosis, so inhibitors of thedeacetylation enzymes might be useful drugs for the reactivation of these p53responses for cancer therapy [29]. This evidence concerns the gene TP53 and cancer.